European Journal of Clinical and Experimental Medicine T.22, z. 1 (2024)
URI dla tej Kolekcjihttps://repozytorium.ur.edu.pl/handle/item/10350
Przeglądaj
Przeglądanie European Journal of Clinical and Experimental Medicine T.22, z. 1 (2024) według Autor "Abubakr, Mohammed Hayati"
Aktualnie wyświetlane 1 - 1 z 1
- Wyniki na stronie
- Opcje sortowania
Pozycja Assessment of serum creatinine, urea, and aminotransferase levels among methamphetamine addicted individuals in Khartoum State(Publishing Office of the University of Rzeszow, 2024-03) Al-Tayeb, Al-Noor Opied; Abubakr, Mohammed Hayati; Elrheima, Hafsa Ahmed; Habbani, Ahmed Khalid; Elrasul, Rami Y. HassabIntroduction and aim. Methamphetamine-use disorder is a pressing global public health issue. In Sudan, the escalating meth amphetamine (METH) consumption has become a significant social and health problem. This study aims to evaluate liver and kidney biomarkers in methamphetamine addicts in Khartoum state Material and methods. The study was an analytical prospective cross-sectional hospital-based study. One hundred partici pants were enrolled in this study, fifty were cases (methamphetamine addicts), and others were healthy non-METH users as a comparative group. Results. METH users had a mean age of (27±7) years and had been using METH for an average of (14±9) months. Urea and cre atinine levels were also significantly elevated in METH users compared to non-users, with p<0.001 and p=0.044, respectively. Their aspartate transaminase (AST) and alanine transaminase (ALT) levels were significantly higher compared to non-users, with p<0.001. Conclusion. There was significant increases in creatinine, urea, and aminotransferases levels in the case group. ALT showed a moderate positive correlation with abuse duration, while AST showed no significant correlation. Urea and creatinine levels had strong and moderate positive correlations with abuse duration, respectively.